样式: 排序: IF: - GO 导出 标记为已读
-
Can Health Literacy Effectively Enhance Blood Donation Rates? Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-09-19 Halime Şentürk, Arda Borlu, Hasan Durmuş, Fevziye Çetinkaya
The main aim of this study was to assess the health literacy level among blood donors and contrast it with the health literacy level observed within the general community. The study encompassed blood donors aged 18 years and older who presented themselves to the Erciyes University Blood Center within the period from February 10, 2023, to April 1, 2023. A questionnaire form including sociodemographic
-
Assessment of Cardiac, Hepatic and Pancreatic Iron Overload in Transfusion Dependent Thalassemia Patients Using T2* Magnetic Resonance Imaging Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-09-17 Vijay Ramanan, Kanchankumar Ramrao Bhagyawant, Onkar Auti, Pratibha Gawande
-
Frameshift Mutation in the EPB41 Gene with Hereditary Elliptocytosis Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-09-14 Xiaobing Sun, Qingwen Zeng, Ruiqing He, Lily Zhou, Qi Hou
-
Through the Eyes of the Recipient: Navigating Transfusion Services Amidst COVID-19 in Multi-Transfused Thalassaemic Patients Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-09-13 Smita Mahapatra, Kaushik Patra, Manu Mangat Marandi, Sabyasachi Acharya
-
Nomogram for the Therapeutic Efficacy of Apheresis Platelet Transfusion in Hematologic Patients Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-09-11 Yiwen He, Huihui Feng, Lu Yu, Gang Deng
-
An In-Depth Analysis of Variable Dynamics Influencing Bone Mineral Density in Transfusion-Dependent Thalassemia Patients Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-09-12 Andri Reza Rahmadi, Febi Ramdhani Rachman, Evan Susandi, Sumartini Dewi, Laniyati Hamijoyo, Dimmy Prasetya, Indra Wijaya, Mohammad Ghozali, Suthat Fucharoen, Ramdan Panigoro
-
Prospective Assessment of Bone Marrow Involvement with Positron Emission Tomography vs Bone Marrow Biopsy in Patients with Lymphoma Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-09-11 Suhas Singla, Sandeep Batra, Pankaj Dougall, Nitin Dayal, Rahul Naithani
Bone marrow (BM) involvement in lymphoma is a known adverse prognostic factor. Bone marrow biopsy (BMB) is the gold standard for detection of bone marrow involvement but is invasive modality. Positron emission tomography with computed tomography (PET-CT) scan has the ability to assess bone marrow involvement. We aimed to assess the concordance of PET-CT for BM involvement with BMB. 75 consecutive newly
-
Advanced Lymphomatoid Granulomatosis Involving the Central Nervous System and Lung Parenchyma Presenting with Speech and Gait Disturbances Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-09-05 Sarthak Wadhera, Rudra Narayan Swain, Shashikant Saini, Charanpreet Singh, Arihant Jain, Amanjit Bal, Gaurav Prakash, Alka Khadwal, Pankaj Malhotra
-
Psychological Determinants of Blood Donation During the COVID-19 Pandemic in Hungary Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-09-06 László Dorner, Georgina Csordás
-
Clinical and Renal Outcomes in Multiple Myeloma with Involved Free Light Chains Exceeding 1000 mg/L at Diagnosis: Insights from an Indian Cohort Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-09-05 Suvir Singh, Kaveri Joshi, Rintu Sharma, Jagdeep Singh, Kunal Jain, Nitish Garg, Nandita Maini, Ekta Bansal
-
Prevalence of IDH1/IDH2 Mutations in Adult Indian Acute Myeloid Leukaemia Patients and Their Impact on Outcome Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-09-05 Poorvi Kapoor, Ruchi Gupta, Sanjeev Ayushi Kaushal, Nivedita Prabhakar Yeramilli, Khaliqur Rahman, Akhilesh Sharma, Ashish Mishra, Faheema Hassan, Dinesh Chandra, Manish K Singh, Rajesh Kashyap
-
Prevalence of Osteonecrosis in Survivors of Childhood Acute Lymphoblastic Leukaemia of Indian Ethnicity Treated with BFM Protocol Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-09-05 Sanjeev Khera, Shijith KP, Rajan Kapoor, Rajiv Kumar, Somali Pattanayak
-
Effects of Different Doses of Oral Iron on Hepcidin and Treatment Response in Iron Deficiency Anemia Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-09-02 Ozlem Beyler, Cengiz Demir, Vehbi Demircan, Murat Kacmaz
Introduction Iron deficiency anemia (IDA) is a common health problem. The hepcidin hormone is the main regulator of systemic iron balance. The body responds to IDA by decreasing hepcidin. This study investigated how different iron supplementation regimens affect hepcidin levels in women with IDA. 87 female participants aged 18–45 years with hemoglobin < 10 g/dL and serum ferritin < 20 ng/ml were assigned
-
Association Between Physical Activity and Fear of Movement in Patients with Hemophilic Arthropathy Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-09-01 Dimple Choudhry, Malika, Sudhir Kumar Atri, Pankaj Kumar, Poonam Dhankher
-
Peaks and Distortions: Evaluation of Irregularities in Capillary Serum Protein Electrophoresis-An Institutional Experience of 980 Cases From Bihar Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-08-29 Iffat Jamal, Shuchismita, Ravi Bhushan Raman, Vijayanand Choudhary
-
Laboratory Profile of Lupus Anticoagulant Positive Cases and its Association with Clinical Presentation- Experience from a Tertiary Care Centre in Southern India Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-08-29 Pranav Raghuram, Mithraa Devi Sekar, Lokeshwari Srinivasan, Prabhu Manivannan, Debdatta Basu, Rakhee Kar
Antiphospholipid syndrome (APS) is an autoimmune disease with specific clinical features and the presence of antiphospholipid antibodies (aPL) like anti-beta2 glycoprotein 1 (anti-β2gp1), anti-cardiolipin antibody (aCL), and/or lupus anticoagulant (LA). The purpose of this study was to evaluate the laboratory profile of LA-positive cases and study its association with various clinical presentations
-
Revisiting the Real-World Prognosis of Intensive Chemotherapy in Elderly Acute Myeloid Leukemia Patients: A Retrospective Analysis from Tokyo Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-08-29 Takeshi Hagino, Reina Saga, Hiroko Hidai, Hisashi Tsutsumi, Hideki Akiyama, Yoshiro Murai, Mayumi Mori, Sayuri Motomura
-
Monocytic Blast Crisis in Chronic Myeloid Leukemia and Its Clinical Relevance in the Era of TKIs Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-08-29 Shuchismita, Iffat Jamal, Vijayanand Choudhary
-
Pediatric Cold Agglutinin Syndrome in the Post-COVID19 Era Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-08-28 Jared Durnford, Ming Wei Lee, Rajat Bhattacharyya, Prasad Iyer
Purpose: This case series describes an increase in the incidence of cold agglutinin syndrome (CAS) in children in Singapore following relaxation of COVID-19-related non-pharmacological interventions (NPIs). Methods: Clinical data of patients diagnosed with CAS from November 2022 to October 2023 following the relaxation of NPIs in October 2022 were collected retrospectively. Data on the number of CAS
-
Effect of Imatinib Mesylate on the Ovarian Reserves of Female Patients with Chronic Myeloid Leukaemia Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-08-27 Tanya Satija, Vanita Suri, Aashima Arora, Nalini Gupta, Naresh Sachdeva, Arihant Jain, Pankaj Malhotra
Purpose: Imatinib mesylate (IM) has transformed the treatment of chronic myeloid leukaemia (CML). The improved life expectancy of CML patients has led to increased attention to the adverse effects of the drug. There are conflicting reports of the impact of IM on the female reproductive system. A few studies suggested that IM may reduce ovarian reserve and cause menstrual irregularities in female patients
-
Association Between the Anemia During Pregnancy and Maternal Intensive Care Unit Admissions: A Systematic Review and Meta-Analysis Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-08-25 Tejaswini B. Darukaradhya, Asmitha Bhateja, Sujata Siwatch, Muhammad Aaqib Shamim, Prakasini Satapathy, Aravind P. Gandhi
-
Metastatic Adenocarcinoma to Bone Marrow Presenting as Microangiopathic Hemolytic Anemia – Diagnostic Issues in a Series of Seven Young Adults Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-08-24 Babu Vishva, Arumugam Pradeep, Nimesh Mishra, Rakhee Kar, Debdatta Basu
-
Original vs. Generic Plerixafor for the Mobilization of Stem Cells in Multiple Myeloma Patients Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-08-22 Süreyya Yiğit Kaya, Yaşa Gül Mutlu, Orhan Kemal Yücel, İlknur Nizam Özen, Ünal Ataş, Elif Melek, Senem Maral, Volkan Karakuş, Leylagül Kaynar, Ömür Gökmen Sevindik
This study investigates the efficacy and safety of generic plerixafor (Pleksor – Gen Pharma) compared to the original plerixafor (Mozobil - Sanofi) in patients with multiple myeloma undergoing ASCT. A total of 59 patients from three centers, who underwent ASCT between 2018 and 2023, were included and divided into two groups: Mozobil (M) group (n = 32) and Pleksor (P) group (n = 27). Plerixafor was
-
A Comprehensive Gap Analysis of Risk Factors for Transfusion Dependent Thalassemia in Siblings Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-08-22 Dolat Singh Shekhawat, Siyaram Didel, Abhishek Purohit, Tanuja Rajial, Charu Sharma, Pratibha Singh, Kuldeep Singh
-
Prognostic Significance of Regulatory T-Cells and PD-1 + CD8 T-Cells in Chronic Myeloid Leukemia Patients Treated with Generic Imatinib Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-08-20 Fen Saj, Ram Vasudevan Nampoothiri, Deepesh Lad, Aditya Jandial, Man Updesh Singh Sachdeva, Parveen Bose, Neelam Varma, Alka Khadwal, Gaurav Prakash, Pankaj Malhotra
-
Sun Ray Appearance in Skull Plasmacytoma Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-08-13 K. S. Lekshmon, Gogulamudi Pradeep Reddy, Manaswinee Mallik, Aditya Jandial, Arihant Jain, Deepesh Lad, Gaurav Prakash, Pankaj Malhotra, Alka Khadwal
-
The Role of Platelet to Lymphocyte Ratio (PLR) in Predicting Early Treatment Response in Diffuse Large B Cell Lymphoma Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-08-12 Kadir Ilkkilic, Bayram Sen, Osman Cure
-
When Eosinophils Speak: A Case of Strongyloides stercoralis Infection Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-08-09 Santiago Gómez-Jordan, Diego Viasus
-
A Prospective Observational Study of the Prognostic Role of Procalcitonin Compared with High Sensitivity C Reactive Protein in Patients ≥ 15Years of Age with Acute Lymphoblastic Leukemia/Lymphoma with Febrile Neutropenia Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-08-06 Satarupa Mohapatra, Prabodha Kumar Das, Ashoka Mahapatra, Suchitra Kumari, Ashutosh Panigrahi
-
Oxidant/Antioxidant Status in Patients with BCR-ABL1 Negative Myeloproliferative Neoplasms Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-08-06 Meriem Benguella-Benmansour, Kebir Boucherit, Naima Mesli
-
Red cell Alloimmunization and its Correlation with Clinical Spectrum & Transfusion Profile in Pediatric Thalassemia Major Patients: Experience from a Tertiary Care Pediatric Center in Northern India Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-08-06 Sruti Pradhan, Braja Kishore Behera, J Bikrant Kumar Prusty, Soumya Satpathy, Kalpana Panda
Background Thalassemia is the most frequent congenital cause of anemia globally, categorized by anomalous hemoglobin production. Lifelong PRBC transfusion with iron chelation therapy is the only therapeutic option available for the majority. Long-term recurrent blood transfusion has its hindrances like RBC alloimmunization. As there is inadequate data on alloimmunization in the pediatric thalassemia
-
Efficacy and Safety of Mitapivat in Pyruvate Kinase Deficiency: A Systematic Review and Meta-analysis of Clinical Trials Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-08-06 Hazem E. Mohammed, Zeyad Bady, Youssef Z. Farhat, Mohamed E. Haseeb, Mohamed Nasser, Francis Eshun, Hussien Ahmed H. Abdelgawad
-
Disseminated Aspergillus Flavus Infection in High-Risk Acute Promyelocytic Leukemia: A Case for Early Recognition and Pharmacokinetic Guided Treatment Approach Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-08-06 Rudra Narayan Swain, Sarthak Wadhera, Richa Ganatra, Charanpreet Singh, Arihant Jain, Gaurav Prakash, Shano Naseem, Uma Nahar Saikia, Manphool Singhal, Alka Khadwal, Pankaj Malhotra
-
Identification of a Novel FUT1 Allele with c.425G > A on the FUT1*01 Allele Background Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-08-06 Lin-Nan Shao, Yi-Cheng Yang, Chun-Xiang Li, Ning Li, Yue-Xin Xia, Shi-Hang Zhou, Xiao-Hua Liang
-
Quality of life in adult patients with hematological malignancy- treading a road less travelled Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-08-02 Akanksha Garg, Kalyani Nair, Samiran Chavan, Megha Mukundan, Parmod Kumar
Introduction Haematological malignancies (HM) comprise of nearly 10% of all cancers. In oncology, the Health- related quality of life (HRQOL) measure assesses the physical, social and mental health aspects of patients undergoing treatment. There is lack of Indian data on HRQOL in patients with haematological malignancies. The main objective of our study was to assess the parameters of quality of life
-
Bilirubin Crystals in Neutrophils Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-08-02 Ramya Chitturi, Divya Sai Pesala, Sushmita Mayilanandan, Sruthi Yaddanapudi, Roseline Gonmei, Aparna Chinnam
-
Novel Mutations in Acute Erythroid Leukemia–A Case Report with Review of Literature Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-07-30 Deepak Jena, Priyavadhana Balasubramanian, Subhajit Hajra, Sunil Kumar Raghav
-
Sideroblastic anemia Secondary to anti-tubercular Therapy in a Patient with Acute Promyelocytic Leukemia Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-07-30 Rudra Narayan Swain, Muskan Arora, Charanpreet Singh, Sreejesh Sreedharanunni
-
Impact of Dedicated Thalassemia Day Care Services: Pediatric Hematologist’s Perspective Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-07-27 Ritika Khurana, Purva Kanvinde, Parth Ganatra, Minnie Bodhanwala, Bharat Aggarwal, Sangeeta Mudaliar
-
Long-Term Outcomes of Allogeneic Stem Cell Transplantation for Relapsed/Refractory Hodgkin and Non-Hodgkin Lymphoma: Multi-center Experience from Turkey Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-07-26 Ayse Uysal, Nur Akad Soyer, Hakan Ozdogu, Hakan Goker, Olgu Erkin Cınar, Burak Deveci, Asu Fergun Yılmaz, Isık Kaygusuz Atagunduz, Ali Irfan Emre Tekgunduz, Sebnem Guner Izmir, Filiz Vural
-
Red Cell Genotyping Helps in Managing a Multi-Transfused Patient with Serologically Inconclusive Results Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-07-25 Ayesha Sinha, Najla Haneefa Basheela, Durba Biswas, Debapriya Basu, Suvro Sankha Datta
-
Peripheral T-Cell Lymphoma Coexisting with Autoimmune Hemolytic Anemia: Analysis of Clinical Features Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-07-25 Ozlem Candan, Narmin Naghizada, Derya Demirtas, Ahmet Mert Yanik, Secil Salim, Meral Ulukoylu Menguc, Fatma Arikan, Asu Fergun Yilmaz, Isık Atagunduz, Ayse Tulin Tuglular, Tayfur Toptas
-
Fungal Pneumonia and Pulmonary Embolism in a Child with Refractory Leukemia: Coincidence or Not? Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-07-20 Zühre Kaya, Merve Yazol, Serap Kirkiz, Büşra Topuz Türkcan, Ahmet Bayramlı, Hasan Tezer, Ülker Koçak
-
Unveiling the Unseen: Candida auris Discovered in a Peripheral Smear of Acute Myeloid Leukemia Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-07-19 Swapnil Tripathi, Himil Parikh, Amiya Ranjan Nayak, Gagandeep Singh, Jasmita Dass, Pradeep Kumar, Mukul Aggarwal
-
Bombay Group Phenotype or Group O Phenotype: A Serological Dilemma Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-07-19 Brinda Kakkar, Mahesh Kulkarni, Sameer Melinkeri, Sanjiv Ketkar, Amruta Keripale
-
Correlation of Flame Cells and Two Monoclonal Bands in Beta and Gamma Region in IgA Multiple Myeloma Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-07-12 Bilal Kazi, Anupam Chakrapani
-
Bone Turnover Markers Levels in a Cohort of Egyptian Children with Sickle Cell Disease Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-07-10 Mona El-Tagui, Sameh Tawfik, Eman Al-Hussain AbdulGawad, Alaa Gad, Mohamed El Sherbiny, Mariam Saad Nassim
-
Assessment of the Prognostic Importance of The Revised International Staging System Based on Plasmacytoma Presentation in Recently Diagnosed Patients with Multiple Myeloma Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-07-10 Rafiye Ciftciler, Ali Erdinc Ciftciler, Mehmet Daglı
-
B Lineage Acute Lymphoblastic Leukemia with concurrent IGH and EPOR rearrangements – An Entity with Dismal Outcome Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-07-10 Nupur Pradhan, Prabhjot Kaur, Venus Thakur, Anshu Anshu, Shailja Rathore, Praveen Sharma, Nabhajit Mallik, Man Updesh Singh Sachdeva, Mirza Saleem Amjad, Reena Das, Arihant Jain, Alka Khadwal, Sreejesh Sreedharanunni
-
Hematopoietic Stem Cell Transplant of a Congenital Dyserythropoietic Anemia Type II Patient: A Rare Report from the Indian Population Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-07-10 Arati Nandan Saptarshi, Kannan Subramaniam, Sandeep Nemani, Tejashree Anil More, Rashmi Dongerdiye, Prabhakar Kedar
-
Imatinib Mesylate Causes Potential Cardiac Dysfunction in Patients With Chronic Myeloid Leukemia: the Results of a Case–control Study Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-07-08 Gowri Shankar, Ankur Jain, Ankur Gupta, Aditya Jandial, Neelam Varma, Arihant Jain, Gaurav Prakash, Alka Khadwal, Pankaj Malhotra
Unlike second-generation tyrosine kinase inhibitors, effects of imatinib on the cardiovascular (CV) system are debatable. The current case–control study aimed to evaluate the CV effects of imatinib in patients with chronic myeloid leukemia (CML) using non-invasive 2D-echocardiography testing. Patients with CML ≥ 13 years attending the adult haematology clinic of a tertiary care hospital in north India
-
Analysis of the Rate and Reasons for Discard Blood and Its Components from 2019 to 2022 in a Single Blood Service in China Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-07-02 Hong Zhu, Wenjuan Han, Liwei Zhu, Ying Lu, Zhuolan Shen, Wenyan Guo, Wei Ding, Faming Zhu
Introduction The discard rate of blood services as a crucial quality metric for monitoring and enhancing blood safety within blood bank operations. This study investigated the prevalence and underlying causes of discarded blood and its associated components at a blood center in China. Materials and Methods This retrospective analysis examined data pertaining to discarded blood and its components from
-
Congenital Dyserythropoietic Anaemia Type II with SEC23B Mutation in Adults: A Case Series Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-07-01 Priyanka Moule, Deepika Gupta, Chetan Agarwal, Sabina Langer, Amrita Saraf, Jyoti Kotwal, Nitin Gupta
-
Daily Versus Alternate Day Oral Iron Replacement for Women with Iron Deficiency Anaemia: A Randomized Controlled Trial Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-06-29 Mallesh Dhanush, Kolar Vishwanath Vinod, Prabhu Manivannan, Prashant S. Adole, Dhanajayan Govindan
-
Evidence of CAR-T Cell Expansion in Peripheral Blood by Unusual Lymphoid Morphology: A Relatively Unexplored Phenomenon Post CAR-T Infusion Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-06-28 Nupur Das, Prashant Mehta, Pravas Mishra, Swati Pabbi, Rahul Katharia, Tanisha Singla, Saphalta Baghmar
-
Haploidentical Hematopoietic Stem Cell Transplantation in India-Bridging the Gap. Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-06-25 Kundan Mishra,Rahul Naithani
-
Genotyping R1336X and Eliminating the Pseudogene Amplification in Type 3 von Willebrand Disease Patients Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-06-24 Mahmoud Khatib, Azam Bolhassani, Zahra Noormohammadi, Maryam Ghazizadeh
-
Renomegaly as a Presentation of T-Acute Lymphoblastic Leukemia Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-06-22 Sarthak Wadhera, Rudra Narayan Swain, Shashikant Saini, Charanpreet Singh, Arihant Jain, Prashant Sharma, Gaurav Prakash, Aravind Sekar, Alka Khadwal, Pankaj Malhotra
-
Significance of Somatic Mutation Profiling in CML Beyond BCR-ABL: A Retrospective Study of the Indian Population Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-06-21 Pooja Chaudhary, Spandan Chaudhary, Falguni Patel, Shiv Patel, Dhiren Patel, Lokesh Patel, Nikha Trivedi, Toral Vaishnani, Ekta Jajodia, Firoz Ahmad, Neeraj Arora
-
Dual Oral Iron Chelation (DOIC) in Children with Transfusion-Dependent Beta Thalassemia: Real-World Efficacy Data Indian J. Hematol. Blood Transfus. (IF 0.7) Pub Date : 2024-06-20 Amitoj Singh Chadha, Abaan Ul Haq Khazi Mohammad, Naveen Kanth Dhãmi Nadakuditi, Surbhi Agrawal, Kenson Sam Alex, Namratha S. Naik, John Michael Raj, Anand Prakash